Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.59p
   
  • Change Today:
      0.030p
  • 52 Week High: 2.61
  • 52 Week Low: 0.85
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 181,321
  • Market Cap: £6.62m
  • RiskGrade: 328

Dividend Data

  31-Dec-2331-Dec-2231-Dec-2131-Dec-2031-Dec-19
Total Dividendn/an/an/an/an/a
For more dividend details, click here

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
Revenue n/a n/a 0.12 0.13 0.08
Operating Profit/(Loss) (3.06) (3.03) (6.59) (5.59) (6.28)
Net Interest (0.36) (1.43) (2.35) (1.66) (0.46)
Profit Before Tax (3.42) (4.46) (8.94) (7.25) (6.74)
Profit After Tax (2.92) (3.81) (8.17) (6.86) (6.12)
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD (2.92) (3.81) (8.17) (6.86) (6.12)
Attributable to:          
Equity Holders of Parent Company (2.92) (3.81) (8.17) (6.86) (6.12)
Minority Interests n/a n/a n/a n/a n/a
           
Continuing EPS          
Earnings per Share - Basic (0.81p) (1.26p) (3.25p) 3.43p (3.99p)
Earnings per Share - Diluted (0.81p) (1.26p) (3.25p) 3.43p (3.99p)
Earnings per Share - Adjusted (0.81p) (1.26p) (3.25p) 3.43p (3.99p)
Continuing and Discontinued EPS          
Earnings per Share - Basic (0.81p) (1.26p) (3.25p) 3.43p (3.99p)
Earnings per Share - Diluted (0.81p) (1.26p) (3.25p) 3.43p (3.99p)
Earnings per Share - Adjusted (0.81p) (1.26p) (3.25p) 3.43p (3.99p)
           
Dividend per Share n/a n/a n/a n/a n/a
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Assets          
Non-Current Assets          
Property, Plant & Equipment 0.10 0.39 0.35 0.41 0.21
Intangible Assets 0.45 0.47 0.48 0.48 0.48
Investment Properties n/a n/a n/a n/a n/a
Investments n/a n/a n/a n/a n/a
Other Financial Assets 0.64 0.69 1.42 2.59 1.53
Other Non-Current Assets 0.18 0.08 0.41 n/a n/a
  1.38 1.64 2.65 3.49 2.22
Current Assets          
Inventories n/a n/a n/a n/a n/a
Trade & Other Receivables 0.47 0.72 0.43 0.16 0.15
Cash at Bank & in Hand 0.21 0.67 1.65 5.86 1.36
Current Asset Investments n/a n/a n/a n/a n/a
Other Current Assets 0.67 0.95 1.27 1.40 2.06
  1.34 2.34 3.35 7.42 3.58
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 2.72 3.97 6.00 10.92 5.80
           
Liabilities          
Current Liabilities          
Borrowings n/a n/a n/a 0.01 0.03
Other Current Liabilities 1.66 1.45 1.58 1.25 0.51
  1.66 1.45 1.58 1.26 0.53
           
Net Current Assets cn/a cn/a cn/a cn/a cn/a
           
Non-Current Liabilities          
Borrowings n/a n/a n/a n/a n/a
Provisions n/a n/a n/a n/a n/a
Other Non-Current Liabilities n/a n/a n/a n/a n/a
  n/a n/a n/a n/a n/a
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 1.66 1.45 1.58 1.26 0.53
           
Net Assets 1.06 2.52 4.41 9.65 5.27
           
Capital & Reserves          
Share Capital 29.81 28.98 28.50 25.02 16.74
Share Premium Account 29.32 28.79 27.24 27.24 27.19
Other Reserves 6.01 5.87 5.26 3.36 1.54
Retained Earnings (64.08) (61.12) (56.58) (45.97) (40.19)
Shareholders Funds 1.06 2.52 4.41 9.65 5.27
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity 1.06 2.52 4.41 9.65 5.27
Cash Flow 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Net Cash Flow From Operating Activities (1.36) (2.35) (4.83) (3.33) (4.22)
Returns On Investment & Servicing of Finance fn/a fn/a fn/a fn/a fn/a
Taxation Paid fn/a fn/a fn/a fn/a fn/a
Net Cash Flow from Investing Activities 0.19 (0.08) (0.05) (0.57) (0.10)
Acquisitions & Disposals gn/a gn/a gn/a gn/a gn/a
Dividends Paid fn/a fn/a fn/a fn/a fn/a
Management of Liquid Resources cn/a cn/a cn/a cn/a cn/a
Net Cash Flow from Financing Activities 0.72 1.55 0.70 8.37 0.33
Net Increase/Decrease In Cash (0.45) (0.88) (4.18) 4.47 (4.00)
Ratios - based on IFRS 31-Dec-23 31-Dec-22 31-Dec-21 31-Dec-20 31-Dec-19
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a 3.9 n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share n/a n/a n/a 0.031p 0.019p
Pre-Tax Profit per Share (0.82p) (1.07p) (0.022p) (1.74p) (1.62p)
Operating Margin n/a n/a (5,565.66%) (4,300.00%) (7,850.00%)
Return on Capital Employed n/a n/a n/a n/a n/a
Continuing & Discontinued Operations          
PE Ratio - Adjusted n/a n/a n/a 3.9 n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share (0.33p) (0.56p) (1.16p) (0.80p) (1.01p)
Cash Incr/Decr per Share (0.11p) (0.21p) (0.010p) 1.07p (0.96p)
Net Asset Value per Share (exc. Intangibles) 0.15p 0.49p 0.94p 2.20p 1.15p
Net Gearing n/a n/a -37.36% -60.62% -25.39%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page